CRISPR

CRISPR1-metrn

ID
ZDB-CRISPR-230919-7
Name
CRISPR1-metrn
Previous Names
None
Target
Sequence
5' - GGATTTCATTCCTGACGGGT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
nt200 metrn
Expression
Gene expression in Wild Types + CRISPR1-metrn
No data available
Phenotype
Phenotype resulting from CRISPR1-metrn
No data available
Phenotype of all Fish created by or utilizing CRISPR1-metrn
Phenotype Fish Conditions Figures
heart contraction increased frequency, abnormal metrnnt200/+; mi2004Tg standard conditions Fig 8 with image from Kikel-Coury et al., 2021
heart has fewer parts of type heart glial cell (sensu Vertebrata), abnormal metrnnt200/nt200; mi2004Tg chemical treatment by environment: S3I-201 Fig 7 with image from Kikel-Coury et al., 2021
cardiac ventricle metrn expression decreased amount, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 6 with image from Kikel-Coury et al., 2021
heart cardiac glial cell differentiation decreased process quality, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 7 with image from Kikel-Coury et al., 2021
cardiac ventricle id1 expression decreased amount, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 6 with image from Kikel-Coury et al., 2021
heart neural crest-derived cardiac glial cell differentiation decreased process quality, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 7 with image from Kikel-Coury et al., 2021
heart contraction frequency, ameliorated metrnnt200/nt200; mi2004Tg chemical treatment by environment: L-isoprenaline Fig 9 with image from Kikel-Coury et al., 2021
heart contraction irregular rhythm, exacerbated metrnnt200/nt200; mi2004Tg chemical treatment by environment: L-isoprenaline Fig 9 with image from Kikel-Coury et al., 2021
heart cardiac glial cell differentiation decreased process quality, abnormal metrnnt200/nt200; mi2004Tg chemical treatment by environment: S3I-201 Fig 7 with image from Kikel-Coury et al., 2021
heart neural crest-derived cardiac glial cell differentiation decreased process quality, abnormal metrnnt200/nt200; mi2004Tg chemical treatment by environment: S3I-201 Fig 7 with image from Kikel-Coury et al., 2021
cardiac ventricle heart contraction irregular rhythm, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 8 with image from Kikel-Coury et al., 2021
heart contraction frequency, ameliorated metrnnt200/nt200; mi2004Tg chemical treatment by environment: carbachol Fig 9 with image from Kikel-Coury et al., 2021
cardiac ventricle cdh11 expression decreased amount, abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 6 with image from Kikel-Coury et al., 2021
heart has fewer parts of type heart glial cell (sensu Vertebrata), abnormal metrnnt200/nt200; mi2004Tg standard conditions Fig 7 with image from Kikel-Coury et al., 2021
Citations